Acurx Pharmaceuticals, Inc. (ACXP) DCF Valuation

ACURX Pharmaceuticals, Inc. (ACXP) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Acurx Pharmaceuticals, Inc. (ACXP) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Acurx Pharmaceuticals, Inc. (ACXP) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca evaluar el valor intrínseco de ACURX Pharmaceuticals, Inc.? Nuestra calculadora ACXP DCF integra datos del mundo real con características integrales de personalización, lo que le permite ajustar los pronósticos y mejorar sus estrategias de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -5.9 -4.6 .0 -12.1 .0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 5.9 4.6 12.8 12.1 14.6 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -11.9 -9.2 -12.8 -24.2 -14.6 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.5 3.2 13.0 9.1 7.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .1
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .0 .1 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -11.9 -9.2 -12.7 -24.2 -14.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.9 -4.6 .1 -12.1 -.2 .1 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF .1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -7
Equity Value 8
Diluted Shares Outstanding, MM 13
Equity Value Per Share 0.60

What You Will Get

  • Real Acurx Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Acurx Pharmaceuticals, Inc. (ACXP).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Acurx Pharmaceuticals, Inc. (ACXP).
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Acurx Pharmaceuticals, Inc. (ACXP)’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Acurx Pharmaceuticals, Inc. (ACXP).
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Acurx Pharmaceuticals, Inc. (ACXP).

Key Features

  • Comprehensive ACXP Data: Pre-filled with Acurx Pharmaceuticals’ historical financials and future projections.
  • Customizable Input Options: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures as needed.
  • Dynamic Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Analysis: Develop various forecast scenarios to evaluate different valuation results.
  • User-Centric Interface: Intuitive, organized, and tailored for both professionals and newcomers.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Acurx Pharmaceuticals, Inc. (ACXP) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures as needed.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation outcomes effectively.
  • 5. Utilize with Assurance: Present well-founded valuation insights to inform your strategic decisions.

Why Choose Acurx Pharmaceuticals Calculator?

  • User-Friendly Interface: Suitable for both novice and experienced users.
  • Customizable Inputs: Easily adjust parameters to suit your evaluation needs.
  • Real-Time Feedback: Watch Acurx’s valuation update instantly as you make changes.
  • Preloaded Data: Comes equipped with Acurx’s latest financial metrics for efficient analysis.
  • Preferred by Analysts: Valued by investors and analysts for making well-informed choices.

Who Should Use Acurx Pharmaceuticals, Inc. (ACXP)?

  • Investors: Gain insights into the pharmaceutical sector with a reliable analysis tool.
  • Financial Analysts: Streamline your workflow with an intuitive model designed for drug development evaluations.
  • Consultants: Easily modify the framework for client-facing presentations or strategic reports.
  • Pharmaceutical Enthusiasts: Enhance your knowledge of drug valuation methodologies through practical examples.
  • Educators and Students: Utilize it as a hands-on resource in pharmaceutical finance courses.

What the Template Contains

  • Historical Data: Includes Acurx Pharmaceuticals' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Acurx Pharmaceuticals' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Acurx Pharmaceuticals' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.